CENTESSA PHARMACEUTICALS (260) — Long-term Investment Intensity
CENTESSA PHARMACEUTICALS (260) has a Long-term Investment Intensity of 40.1% as of March 2026. Long-term investments of €257.12 Million represent 40.1% of total assets of €641.76 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 260 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
CENTESSA PHARMACEUTICALS Long-term Investment Intensity (2025–2025)
This chart shows how CENTESSA PHARMACEUTICALS's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of March 2026, the intensity stands at 40.1%, reflecting long-term investments of €257.12 Million against total assets of €641.76 Million EUR. See defensive interval ratio of CENTESSA PHARMACEUTICALS to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for CENTESSA PHARMACEUTICALS (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for CENTESSA PHARMACEUTICALS from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CENTESSA PHARMACEUTICALS asset portfolio.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 41.1% | €282.55 Million | €687.50 Million | — |